Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: A4HDF1
Term | Name | Level | Count |
---|---|---|---|
GO:0043085 | positive regulation of catalytic activity | 4 | 1 |
GO:0043087 | regulation of GTPase activity | 5 | 1 |
GO:0043547 | positive regulation of GTPase activity | 6 | 1 |
GO:0044093 | positive regulation of molecular function | 3 | 1 |
GO:0050790 | regulation of catalytic activity | 3 | 1 |
GO:0051336 | regulation of hydrolase activity | 4 | 1 |
GO:0051345 | positive regulation of hydrolase activity | 5 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065009 | regulation of molecular function | 2 | 1 |
GO:0090630 | activation of GTPase activity | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005096 | GTPase activator activity | 4 | 1 |
GO:0008047 | enzyme activator activity | 3 | 1 |
GO:0030234 | enzyme regulator activity | 2 | 1 |
GO:0030695 | GTPase regulator activity | 4 | 1 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 3 | 1 |
GO:0098772 | molecular function regulator activity | 1 | 1 |
GO:0140677 | molecular function activator activity | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 95 | 99 | PF00656 | 0.466 |
CLV_NRD_NRD_1 | 454 | 456 | PF00675 | 0.539 |
CLV_PCSK_SKI1_1 | 126 | 130 | PF00082 | 0.428 |
CLV_PCSK_SKI1_1 | 195 | 199 | PF00082 | 0.650 |
CLV_PCSK_SKI1_1 | 357 | 361 | PF00082 | 0.492 |
CLV_PCSK_SKI1_1 | 456 | 460 | PF00082 | 0.532 |
CLV_PCSK_SKI1_1 | 467 | 471 | PF00082 | 0.419 |
CLV_PCSK_SKI1_1 | 58 | 62 | PF00082 | 0.504 |
DEG_APCC_DBOX_1 | 356 | 364 | PF00400 | 0.464 |
DOC_CDC14_PxL_1 | 442 | 450 | PF14671 | 0.545 |
DOC_CYCLIN_RxL_1 | 192 | 201 | PF00134 | 0.610 |
DOC_CYCLIN_yCln2_LP_2 | 41 | 44 | PF00134 | 0.484 |
DOC_CYCLIN_yCln2_LP_2 | 61 | 67 | PF00134 | 0.500 |
DOC_MAPK_gen_1 | 107 | 116 | PF00069 | 0.591 |
DOC_MAPK_MEF2A_6 | 126 | 133 | PF00069 | 0.400 |
DOC_PP1_RVXF_1 | 24 | 31 | PF00149 | 0.393 |
DOC_PP1_RVXF_1 | 56 | 63 | PF00149 | 0.505 |
DOC_PP2B_LxvP_1 | 4 | 7 | PF13499 | 0.513 |
DOC_PP2B_LxvP_1 | 41 | 44 | PF13499 | 0.484 |
DOC_USP7_MATH_1 | 173 | 177 | PF00917 | 0.747 |
DOC_USP7_MATH_1 | 184 | 188 | PF00917 | 0.516 |
DOC_USP7_MATH_1 | 207 | 211 | PF00917 | 0.732 |
DOC_USP7_MATH_1 | 404 | 408 | PF00917 | 0.492 |
DOC_WW_Pin1_4 | 60 | 65 | PF00397 | 0.502 |
DOC_WW_Pin1_4 | 73 | 78 | PF00397 | 0.463 |
LIG_14-3-3_CanoR_1 | 18 | 27 | PF00244 | 0.400 |
LIG_14-3-3_CanoR_1 | 313 | 323 | PF00244 | 0.492 |
LIG_Actin_WH2_2 | 94 | 111 | PF00022 | 0.457 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.510 |
LIG_BRCT_BRCA1_1 | 58 | 62 | PF00533 | 0.504 |
LIG_EH1_1 | 191 | 199 | PF00400 | 0.647 |
LIG_EVH1_1 | 4 | 8 | PF00568 | 0.512 |
LIG_FHA_1 | 203 | 209 | PF00498 | 0.684 |
LIG_FHA_1 | 232 | 238 | PF00498 | 0.697 |
LIG_FHA_1 | 342 | 348 | PF00498 | 0.476 |
LIG_FHA_1 | 425 | 431 | PF00498 | 0.357 |
LIG_FHA_1 | 448 | 454 | PF00498 | 0.536 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.575 |
LIG_FHA_2 | 11 | 17 | PF00498 | 0.455 |
LIG_FHA_2 | 139 | 145 | PF00498 | 0.582 |
LIG_FHA_2 | 191 | 197 | PF00498 | 0.651 |
LIG_FHA_2 | 35 | 41 | PF00498 | 0.463 |
LIG_FHA_2 | 371 | 377 | PF00498 | 0.444 |
LIG_LIR_Gen_1 | 147 | 157 | PF02991 | 0.452 |
LIG_LIR_Gen_1 | 373 | 382 | PF02991 | 0.492 |
LIG_LIR_Nem_3 | 147 | 153 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 320 | 325 | PF02991 | 0.378 |
LIG_LIR_Nem_3 | 373 | 378 | PF02991 | 0.436 |
LIG_LIR_Nem_3 | 59 | 65 | PF02991 | 0.500 |
LIG_NRBOX | 302 | 308 | PF00104 | 0.492 |
LIG_Pex14_2 | 352 | 356 | PF04695 | 0.357 |
LIG_PTB_Apo_2 | 151 | 158 | PF02174 | 0.593 |
LIG_PTB_Phospho_1 | 151 | 157 | PF10480 | 0.589 |
LIG_Rb_LxCxE_1 | 437 | 450 | PF01857 | 0.543 |
LIG_REV1ctd_RIR_1 | 383 | 391 | PF16727 | 0.492 |
LIG_SH2_CRK | 125 | 129 | PF00017 | 0.372 |
LIG_SH2_CRK | 20 | 24 | PF00017 | 0.393 |
LIG_SH2_CRK | 268 | 272 | PF00017 | 0.421 |
LIG_SH2_CRK | 293 | 297 | PF00017 | 0.492 |
LIG_SH2_CRK | 417 | 421 | PF00017 | 0.492 |
LIG_SH2_SRC | 73 | 76 | PF00017 | 0.512 |
LIG_SH2_STAP1 | 157 | 161 | PF00017 | 0.619 |
LIG_SH2_STAP1 | 417 | 421 | PF00017 | 0.492 |
LIG_SH2_STAP1 | 465 | 469 | PF00017 | 0.588 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.399 |
LIG_SH2_STAT5 | 157 | 160 | PF00017 | 0.617 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.567 |
LIG_SH2_STAT5 | 268 | 271 | PF00017 | 0.469 |
LIG_SH2_STAT5 | 293 | 296 | PF00017 | 0.448 |
LIG_SH2_STAT5 | 402 | 405 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 440 | 443 | PF00017 | 0.540 |
LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.512 |
LIG_SH3_3 | 2 | 8 | PF00018 | 0.510 |
LIG_SH3_3 | 232 | 238 | PF00018 | 0.768 |
LIG_SH3_3 | 356 | 362 | PF00018 | 0.492 |
LIG_SH3_3 | 41 | 47 | PF00018 | 0.478 |
LIG_SH3_3 | 69 | 75 | PF00018 | 0.506 |
LIG_SUMO_SIM_anti_2 | 37 | 43 | PF11976 | 0.476 |
LIG_TRAF2_1 | 141 | 144 | PF00917 | 0.605 |
LIG_TRAF2_1 | 258 | 261 | PF00917 | 0.556 |
LIG_TYR_ITIM | 123 | 128 | PF00017 | 0.524 |
LIG_UBA3_1 | 328 | 334 | PF00899 | 0.240 |
MOD_CK1_1 | 201 | 207 | PF00069 | 0.521 |
MOD_CK1_1 | 380 | 386 | PF00069 | 0.486 |
MOD_CK1_1 | 424 | 430 | PF00069 | 0.492 |
MOD_CK1_1 | 463 | 469 | PF00069 | 0.435 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.461 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.607 |
MOD_CK2_1 | 190 | 196 | PF00069 | 0.615 |
MOD_CK2_1 | 207 | 213 | PF00069 | 0.688 |
MOD_CK2_1 | 254 | 260 | PF00069 | 0.322 |
MOD_CK2_1 | 370 | 376 | PF00069 | 0.379 |
MOD_CK2_1 | 422 | 428 | PF00069 | 0.492 |
MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.743 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.656 |
MOD_GlcNHglycan | 213 | 217 | PF01048 | 0.607 |
MOD_GlcNHglycan | 221 | 224 | PF01048 | 0.501 |
MOD_GlcNHglycan | 229 | 232 | PF01048 | 0.641 |
MOD_GlcNHglycan | 252 | 255 | PF01048 | 0.572 |
MOD_GlcNHglycan | 256 | 259 | PF01048 | 0.497 |
MOD_GlcNHglycan | 283 | 286 | PF01048 | 0.450 |
MOD_GlcNHglycan | 316 | 319 | PF01048 | 0.492 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.484 |
MOD_GSK3_1 | 198 | 205 | PF00069 | 0.632 |
MOD_GSK3_1 | 227 | 234 | PF00069 | 0.651 |
MOD_GSK3_1 | 250 | 257 | PF00069 | 0.504 |
MOD_GSK3_1 | 314 | 321 | PF00069 | 0.408 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.576 |
MOD_N-GLC_1 | 10 | 15 | PF02516 | 0.467 |
MOD_N-GLC_1 | 294 | 299 | PF02516 | 0.492 |
MOD_NEK2_1 | 152 | 157 | PF00069 | 0.486 |
MOD_NEK2_1 | 198 | 203 | PF00069 | 0.652 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.446 |
MOD_NEK2_1 | 422 | 427 | PF00069 | 0.492 |
MOD_NEK2_1 | 56 | 61 | PF00069 | 0.661 |
MOD_NEK2_1 | 65 | 70 | PF00069 | 0.462 |
MOD_NEK2_1 | 9 | 14 | PF00069 | 0.477 |
MOD_NEK2_2 | 190 | 195 | PF00069 | 0.598 |
MOD_NEK2_2 | 318 | 323 | PF00069 | 0.492 |
MOD_PK_1 | 242 | 248 | PF00069 | 0.576 |
MOD_PKA_2 | 318 | 324 | PF00069 | 0.492 |
MOD_PKA_2 | 460 | 466 | PF00069 | 0.550 |
MOD_Plk_1 | 109 | 115 | PF00069 | 0.519 |
MOD_Plk_1 | 134 | 140 | PF00069 | 0.463 |
MOD_Plk_1 | 28 | 34 | PF00069 | 0.497 |
MOD_Plk_1 | 294 | 300 | PF00069 | 0.492 |
MOD_Plk_1 | 56 | 62 | PF00069 | 0.506 |
MOD_Plk_2-3 | 365 | 371 | PF00069 | 0.412 |
MOD_Plk_4 | 242 | 248 | PF00069 | 0.678 |
MOD_Plk_4 | 318 | 324 | PF00069 | 0.412 |
MOD_Plk_4 | 377 | 383 | PF00069 | 0.383 |
MOD_Plk_4 | 460 | 466 | PF00069 | 0.433 |
MOD_ProDKin_1 | 60 | 66 | PF00069 | 0.501 |
MOD_ProDKin_1 | 73 | 79 | PF00069 | 0.462 |
TRG_DiLeu_BaLyEn_6 | 23 | 28 | PF01217 | 0.385 |
TRG_ENDOCYTIC_2 | 125 | 128 | PF00928 | 0.363 |
TRG_ENDOCYTIC_2 | 157 | 160 | PF00928 | 0.617 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.396 |
TRG_ENDOCYTIC_2 | 293 | 296 | PF00928 | 0.492 |
TRG_ENDOCYTIC_2 | 364 | 367 | PF00928 | 0.339 |
TRG_ENDOCYTIC_2 | 417 | 420 | PF00928 | 0.369 |
TRG_NES_CRM1_1 | 376 | 388 | PF08389 | 0.461 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7WY95 | Leishmania donovani | 87% | 100% |
A0A422NHQ9 | Trypanosoma rangeli | 39% | 100% |
A4I0T4 | Leishmania infantum | 87% | 100% |
D0A763 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AWT6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
Q4QAN8 | Leishmania major | 87% | 100% |
V5BAM9 | Trypanosoma cruzi | 38% | 100% |